In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Masimo IP Verdict A Timely Warning For All Device Inventors, Says Counsel

Executive Summary

Masimo Corp. has spent much time and effort over the last decade and a half addressing patent and IP issues surrounding its pulse oximetry technology – and it’s not over yet: an ongoing case with Philips and a future case with Mindray Medical will keep the company busy for some time to come. But for Masimo’s legal counsel, these cases underline the vital need for appropriate protection of inventions – and not just for the company’s benefit.

You may also be interested in...



COVID-19: UK NHS Chief Calls For 90% Return To Planned Care Within 3 Months

The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.

Germany’s ‘Future Hospitals’ Draft Law Needs Sharp Focus On Digital And Robotics Investment

Hospital administrators and clinicians in Germany seek enhanced digitization of clinical procedures, but the budgets have not always been available. A new “future hospitals investment” program, now made into a draft law, should reserve funds for robotics and digital health care.

Device Week, 7 August 2020: Brexit, COVID-19 & NHS Reform Augur Big 12 Months For UK Medtech

In this Device Week, Ashley Yeo asks PB Consulting managing director Dan Jones about the adjustments needed by UK medtechs as they face a confluence of change brought about by Brexit, COVID-19 and NHS reform, at a time when the MHRA is also coming under increased scrutiny. 

Topics

Related Companies

UsernamePublicRestriction

Register

LL1129788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel